Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
PRLD
#2987
Prelude Therapeutics Incorporated
2.7
6
-5.80%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
-5.80%
Monthly Change
+28.37%
6 month change
+113.95%
Cambio anual
+253.85%
Cierres anteriores
2.9
3
Open
2.7
6
Bid
Ask
Low
2.7
6
High
2.7
6
Volumen
3
Markets
Acciones
Atención Sanitaria
PRLD
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
Noticias
Prelude Therapeutics: Citizens bestätigt "Market Outperform" und Kursziel von 3,00 $
Prelude Therapeutics stock gets reiterated Market Outperform rating at Citizens
Prelude Therapeutics: Aktie legt nach FDA-Zulassung für Krebsmedikament deutlich zu
Prelude Therapeutics stock surges after FDA clears IND for cancer drug
Tracking Baker Brothers Portfolio – Q3 2025 Update (NASDAQ:INCY)
Prelude Therapeutics: Citizens bestätigt ’Market Outperform’-Rating
Prelude Therapeutics stock rating reiterated at Market Outperform by Citizens
Incyte: Leiter des Rechnungswesens verkauft Aktien im Wert von 79.000 $
Beat the Market the Zacks Way: Goldman Sachs, Micron, Prelude in Focus
Prelude Therapeutics stock rating reiterated at Market Outperform by Citizens
Incyte-Aktie erreicht 52-Wochen-Hoch von 108,81 USD
Prelude Therapeutics übertrifft im dritten Quartal die Gewinnerwartungen – Aktie zeigt sich stabil